Methylphosphonate (MP) oligodeoxynucleotides (MPOs) are metabolically stable analogs of conventional DNA containing a methyl group in place of one of the non-bonding phosphoryl oxygens. All 16 possible chiral R P MP dinucleotides were synthesized and derivatized for automated oligonucleotide synthesis. These dimer synthons can be used to prepare (i) all-MP linked oligonucleotides having defined R P chirality at every other position (R P chirally enriched MPOs) or (ii) alternating R P MP/phosphodiester backbone oligonucleotides, depending on the composition of the 3′-coupling group. Chirally pure dimer synthons were also prepared with 2′-O-methyl sugar modifications. Oligonucleotides prepared with these R P chiral methylphosphonate linkage synthons bind RNA with significantly higher affinity than racemic MPOs.
INTRODUCTION
Antisense oligonucleotides inhibit protein synthesis by binding to mRNA by Watson-Crick pairing (1) (2) (3) (4) . These compounds prevent processing or translation of mRNA, either by blocking protein recognition or directing nucleases to degrade the message. Methylphosphonate oligonucleotides (MPOs) are among the first oligonucleotide analogs reported to inhibit protein synthesis through a blocking antisense mechanism in cell-free and cell culture assays (5) (6) (7) (8) (9) . MPOs are highly resistant to metabolic breakdown in biological systems (10, 11) . Unlike natural phosphodiester oligonucleotides, MPOs contain chiral linkages. The conventional methods for synthesizing MPOs are not capable of forming methylphosphonate bonds without P epimerization. A typical racemic 18mer MPO contains 131 072 (2 17 ) different diastereomers.
Several investigators have produced short strands of chirally enriched (or chirally pure) MPOs through solution phase approaches (12) (13) (14) . The published procedures take advantage of the differences in chromatographic mobility for 2′-deoxy methylphosphonate (MP) dimers having the R P versus S P configuration (the absolute configurations for the 16 MP dimers are assigned and their physical characteristics described in the literature; 15, 16) . Dimers are separated into R P and S P chiral forms and then coupled to a monomer in solution to yield two trimer diastereomers (R P /S P and R P /R P ). These, in turn, are separated and further coupled to produce tetramers. So far, the ability to resolve different diastereomers is limited to septamers and still requires sequential coupling reactions in order to limit the number of diastereomers in each separation step (12) . In a separate study, two chiral oligothymidine tetramers were coupled together to generate chirally enriched octamers having a single racemic linkage in the middle of the sequence (13, 14) . In both cases, R P chiral MPO-DNA duplexes were significantly more stable to thermal denaturation than S P chiral MPOs. These results are encouraging, but published solution phase procedures are prohibitive for preparing longer oligonucleotides. Solid phase synthesis of chirally pure MPO dimers was recently described (17) and synthesis of longer sequences is under development (18) (19) (20) (21) (22) .
In an effort to provide a method for solid phase assembly of R P chirally enriched MPOs, R P chiral methylphosphonate dimers were coupled sequentially, producing racemic MP linkages at every other position (Fig. 1a) . Each of the 16 possible R P chiral dimers ('dimer synthons') were prepared and derivatized for use in an automated solid phase DNA synthesizer as both the methylphosphonamidites and β-cyanoethyl phosphoramidites to prepare both the MP/MP (Fig. 1a) and MP/phosphodiester (DE) oligomers (Fig. 1b) . Additionally, an oligonucleotide was prepared from a dimer synthon with 2′-O-methyl sugar modifications (Fig. 1c ). Oligonucleotides prepared with these different dimer synthons were shown to hybridize to their RNA targets with binding constants ranging from 10 5 to 10 13 .
Finally, oligodeoxynucleotides containing alternating MP/DE backbones are highly nuclease resistant in vitro. Oligonucleotides containing MP/DE backbones in combination with 2′-O-methyl sugar modifications are almost completely resistant to nuclease degradation in vivo. 5′-O-Dimethoxytrityl-N4-isobutyryl-2′-O-methylcytidine was prepared using standard procedures (23) . 5′-O-Dimethoxytrityl-(base protected)-(2′-deoxy or 2′-O-methyl) nucleosides were phosphitylated with chloromethyl-N,N-diisopropylaminophosphine as published (24) . The 3′-O-t-butyldimethylsilyl-(base protected)-(2′-deoxy or 2′-O-methyl) nucleosides were prepared by 3′-Osilylation of the corresponding 5′-O-dimethoxytrityl-(base protected)-(2′-deoxy or 2′-O-methyl) nucleosides, followed by 5′-O-detritylation with benzenesulfonic acid (25) . Base protecting groups used in these syntheses were N 6 -benzoyl for adenine, N 2 -isobutyryl for guanine and N 4 -isobutyryl for cytidine.
MATERIALS AND METHODS

Synthesis
The general method for preparing 2′-deoxymethylphosphonate dimer synthons is shown in Figure 2 . As examples, the syntheses of 2′-deoxy-(CT) and 2′-O-methyl-(CU) dimer synthons are described below.
Bis-[2′-Deoxy]-5′-O-dimethoxytrityl-(base protected) R P methylphosphonate (CT) dinucleotide.
The 2′-deoxy R P methylphosphonate (CT) dinucleotide was prepared essentially as described previously (15) . Briefly, 3′-O-t-butyldimethylsilyl thymidine was reacted with 5′-O-dimethoxytrityl-N 4 -isobutyryl-2′-deoxycytidine-3′-O-(methyl-N,N-diisopropylaminophosphonamidite) in the presence of tetrazole and then treated with oxidizer solution (275 ml, iodine/water/lutidine/tetrahydrofuran, 25 g/2.5 ml/100 ml/900 ml). The crude product was separated into fast (R P ) and slow (S P ) isomers by flash column chromatography on silica gel (230-400 mesh). The column was step-eluted with ethyl acetate/ dichloromethane (75:25) containing increasing amounts of methanol (1, 2 or 3%). The 3′-O-silyl protecting groups were removed by treatment with tetrabutylammonium fluoride (1 M in tetrahydrofuran). The resulting compound was purified by flash column chromatography on silica gel as just described. 1 
Bis-[2′-O-methyl]-5′-O-dimethoxytrityl-(base protected) methylphosphonate (CU) dinucleotide (fast isomer).
The 2′-O-methyl R P methylphosphonate (CU) dinucleotide was prepared according to a similar procedure. Briefly, 3′-O-t-butyldimethylsilyl 2′-Omethyluridine (6 mmol) and 5′-O-dimethoxytrityl-N 4 -isobutyryl-2′-O-methylcytidine-3′-O-(methyl-N,N-diisopropylaminophosphonamidite) (7 mmol) were dissolved in dry acetonitrile and treated with molecular sieves (3 Å) for 24 h. The two solutions were then mixed under argon and reacted with tetrazole (94 ml, 42 mmol) at room temperature for 4 min. The reaction mixture was then treated with a single addition of cumene hydroperoxide (8.1 mmol). This mixture was rapidly stirred for 10 min and quenched by addition of aqueous sodium bisulfite solution (1 g/ 10 ml). The crude material was fractionated into 'fast' and 'slow' isomers by flash column chromatography and then desilylated and repurified as described above. 1 Phosphitylation of dimer dinucleotides. The chirally pure 5′-(Odimethoxytrityl)-(base protected) methylphosphonate dinucleosides were converted to the corresponding methylphosphonamidites or β-cyanoethyl phosphoramidites using standard procedures (23, 26, 27) . Purities were confirmed by 1 H and 31 P NMR.
Oligonucleotide synthesis
Oligonucleotides were synthesized on a Biosearch Expedite™ Model 8909 DNA synthesizer according to the manufacturer's recommendations except where indicated. Oligonucleotides containing MP linkages were deprotected as described previously (28) and purified by HPLC with a normal phase column matrix (β-Cyclobond 2000; Astec Inc., Whippany, NJ) using a reverse gradient of 60-30% acetonitrile in 0.1 M ammonium acetate, pH 6. The purity of each oligonucleotide was confirmed by polyacrylamide gel electrophoresis and/or ESI-MS analysis (29) .
MP/DE oligodeoxynucleotides. The racemic, alternating MP/DE oligonucleotides were synthesized using a combination of nucleoside β-cyanoethylphosphoramidites (Glen Research Corp., Sterling, VA) and nucleoside methylphosphonamidites (JBL Scientific Inc., San Luis Obispo, CA). Isobutyryl-protected cytidine monomers were used (instead of benzoyl) to prevent transamination when deprotecting with ethylenediamine (28) . A specially prepared oxidizing solution containing 0.25% water was used with methylphosphonamidite monomers, since methylphosphonite diester intermediates are highly sensitive to water (30) . A commercially available oxidizing solution containing 2% water was used with β-cyanoethylphosphoramidite monomers (Glen Research Corp.). The synthesizer was reprogrammed to include these oxidations in each subroutine. The remainder of the synthetic cycle was identical to that used for a standard MPO synthesis (30) .
R P chirally enriched all-MP oligodeoxynucleotides. Bis-[2′-
deoxy]-5′-O-dimethoxytrityl-(base protected) R P methylphosphonate dinucleotide 3′-methylphosphonamidite dimer synthons were dissolved in dry acetonitrile (0.1 M) and dried over 3 Å molecular sieves for at least 24 h before loading onto the synthesizer. The coupling cycle was increased to 1 min/dimer addition. Other coupling reagents were as previously described for conventional racemic MPOs (30) .
Alternating all-2′-deoxy-[(Rp MP)/DE] and all-2′-O-methyl-[(fast isomer MP)/DE] oligonucleotides.
The appropriate chirally pure dimer synthons were dissolved in dry acetonitrile (0.1 M) and dried over 3 Å molecular sieves as described above before loading onto the synthesizer. Standard reagents and conditions were used as recommended by the manufacturer, except that the coupling times were increased to 2 min/addition for the all-2′-deoxy dimers and 3 min/dimer addition for the all-2′-O-methyl dimers.
RNA and DNA oligonucleotides. RNA oligonucleotides were synthesized as previously described (31, 32) . The phosphodiester oligomer was purchased from Oligos Etc. (Danbury, CT).
Spectroscopic and native gel determination of binding constants for oligonucleotides annealed to complementary synthetic RNA targets
Standard nearest neighbor extinction coefficients (33) were found to be independent of backbone types in this report within experimental error (unpublished data). Annealing reaction mixtures contained equimolar amounts of antisense oligonucleotide analog and RNA target oligonucleotide (∼2.4 µM total strand concentration), 20 mM potassium phosphate, pH 7.2, 100 mM sodium chloride, 0.1 mM EDTA and 0.03% potassium sarkosylate. The antisense oligonucleotide/RNA mixtures were heated to 80_C, cooled slowly to room temperature and chilled to 4_C over w2 h. The annealed samples were transferred to 1 cm quartz cuvettes (chilled to 4_C) and placed in a Varian Cary Model 3E Spectrophotometer containing a temperature controlled 6 × 6 sample holder (pre-cooled to 5_C). Denaturation was monitored at 260 nM as a function of temperature, increasing from 5 to 80_C at a ramp rate of 1_C/min. These data were fitted to a two-state model of duplex dissociation, assuming sloping linear baselines and temperature-independent ∆H_ and ∆S_ (34). Each measurement was repeated at least three times at the same concentration, using independent samples. Thermodynamics from 1/T m versus log C t /4 plots were not determined, since measurements were made within a limited concentration range of less than one order of magnitude; typically these plots require data over a concentration range of at least two orders of magnitude.
The duplex binding constant was determined independently by gel mobility shift experiments, similar to published procedures (35) . Gel mobility was measured in 0.1 M NaCl, 0.01 M dibasic sodium phosphate and 1 mM EDTA, 0.04 M Tris base, pH 8.0, at 0_C in 16% polyacrylamide gels (19:1 acrylamide:bisacrylamide). RNA was 5′-32 P-labeled using Stratagene T4 polynucleotide kinase and NEN [γ-32 P]ATP and purified using a NEN Nensorb column. Labeled RNA concentrations were ∼10 -11 M, while oligonucleotides were added over a concentration range of ∼10 -11 to 10 -5 M. Samples were annealed by slow cooling from 90 to 37_C and incubated at 37_C for 48 h before snap freezing on dry ice. A non-Nucleic Acids Research, 1996, Vol. 24 
where f m is the fraction of radiation in the slower, duplex band, B 0 is the total concentration of the unlabeled oligomer and R 0 is the total concentration of the labeled RNA.
In vitro nuclease stability studies of various backbonemodified oligonucleotides
Stability in the presence of fetal calf serum. Fetal bovine serum (Gemini Bioproducts Inc.) was diluted in Dulbecco's phosphatebuffered saline (Mediatech Inc.) to a final concentration of 10% (v/v). Aliquots were mixed with oligonucleotide on ice (0.075 OD 260 U/sample), incubated at 37_C for the specified time intervals and then quickly frozen in a dry ice/isopropanol bath. Then, samples were thawed individually and analyzed by reversed phase HPLC using a Vydac C4 Protein column (4.6 × 250 mm). Elution was performed with solvents buffer A (50 mM TEAA, pH 7.0, 1% acetonitrile) and buffer B (50 mM TEAA, pH 7.0, 50% acetonitrile). The flow rate was 1.0 ml/min and the gradient conditions for each backbone were as follows: all-DE backbone, 5-25% buffer B (2.5-9.0 min), 25-45% buffer B (9.0-22. Stability in the presence of cell lysate from African green monkey kidney (COS-7) cells. COS-7 cells were grown to 90% confluency and harvested in the presence of 0.25% trypsin. The cell pellets were washed with phosphate-buffered saline and then frozen at -20_C. The pellets were resuspended in an equal volume of lysis buffer (2.5 mM HEPES, pH 7.2, 2 mM MgCl 2 , 0.1% NP-40) and centrifuged at 10 000 g for 5 min. Approximately 60% of the supernatant was separated and the remainder was left with the cell pellet, which was resuspended in a dounce homogenizer (type A pestle). This suspension was centrifuged as above and the supernatant was combined with the original aliquots removed from the previous step to give a final lysis suspension. Samples were buffered with either Tris-acetate (25 mM, final pH 7.4) or 2-(N-morpholino)ethanesulfonate (MES, 25 mM, final pH 6.0) prior to addition of oligomer. This mixture was incubated at 37_C and analyzed as described.
Stability in the presence of Escherichia coli cell lysate. Approximately 2 × 10 11 cells of E.coli ES142 were pelleted by centrifugation, resuspended in Tris-HCl buffer (10 ml, 50 mM, pH 7.5) and incubated at room temperature for 5 min. Dithiothreitol and lysozyme were added to give final concentrations of 2 mM and 1 mg/ml respectively and the suspension was incubated at 37_C for 30 min. The mixture was treated to several rounds of sonication and freeze/thawing and centrifuged at 6000 g for 5 min. The volume of the final supernatant was estimated to be ∼57 times the volume of the original cell pellet. Aliquots of this lysate were mixed with oligonucleotides, incubated at 37_C and analyzed as described.
Stability in the presence of Staphylococcal aureus cell lysate. Cell lysate of S.aureus MI273 was prepared and analyzed as described for the E.coli preparation with the following modifications: (i) the lysis was conducted with a cell pellet containing ∼4 × 10 10 cells; (ii) lysostaphin was used instead of lysozyme (500 U; Sigma Chemical Co.).
In vivo stability study in male Sprague-Dawley rats. A tritium labeled, 2′-O-methyl alternating MP/DE backbone oligonucleotide was synthesized with the sequence 5′-T-(
H-methyl]phosphonamidite coupling moiety (36).
The oligonucleotide was suspended in Dulbecco's phosphatebuffered saline (Mediatech Inc.) and shipped to an outside vendor (Biodevelopment Laboratories Inc., Cambridge, MA) for injection (via tail vein) into cannulated male Sprague-Dawley rats (∼250 g) at a dose of 2 mg/kg. Urine and blood samples were collected from animals at specified intervals. Blood samples were separated into plasma and cell pellets by centrifugation. Samples were frozen in liquid nitrogen and then shipped back to Genta Inc. for HPLC analysis. Upon receipt, the urine and plasma samples were thawed and diluted with an equal volume of acetonitrile to precipitate proteins. NP-40 was also added to a final concentration of 0.1%. The samples were then spun for 15 min in a microcentrifuge. Negligible radioactivity was detected in the protein pellets. The supernatants were analyzed by reversed phase HPLC as described above. The gradient used for these samples was as follows: 5-45% buffer B (2.5-12.5 min), 45-90% buffer B (12.5-22.5 min).
RESULTS
Chirally pure dimer synthons with methylphosphonate internucleosidyl linkages
The method for the separation and derivatization of 2′-deoxy R P MP dimer synthons is illustrated in Figure 2 . Each of the 16 possible dimers were prepared as a mixture of R P and S P diastereomers. The dimethoxytritylated, base-protected diastereomers were separated by silica gel flash chromatography. In all cases, the R P diastereomer eluted on silica gel chromatography with faster mobility (15) . The desired diastereomer was isolated and derivatized (for coupling on an automated DNA synthesizer). Derivatization at the 3′-end enabled the dimers to be coupled together via either racemic MP linkages, generating all-MP backbones with R P linkages at every other position, or prochiral DE linkages, yielding alternating R P MP/DE backbones.
The preparation of 2′-O-methyl chiral MP dimer synthons was by analogous procedures, but with several key modifications. First, the reaction time for coupling the two 2′-O-methyl monomers together was increased from 3 (as in the case of 2′-deoxy monomers) to 5 min, to drive the reaction to completion. Second, we found cumene hydroperoxide oxidation gave a more favorable ratio of 'fast' versus 'slow' diastereomers compared with iodine oxidizer reagents (unpublished results). Third, baseline separation of the 'fast' and 'slow' diastereomers was not always achieved using flash column chromatography, even when the amount of silica gel was increased 10-fold. Where necessary, the two diastereomers were further purified by reversed phase HPLC following removal of the 3′-O-silyl protecting group.
We chose the 'fast' eluting diastereomers of the 2′-O-methyl MP dimers for further derivatization and incorporation into oligonucleotides, analogous to 'fast' eluting 2′-deoxy R P MP dimers (12, 15) . This seemed to be a reasonable first choice, since the 2′-O-methyl groups were not expected to affect the relative chromatographic mobilities of the two diastereomers. In practice, all of the oligonucleotides prepared with 2′-O-methyl (fast isomer MP) dimers have higher binding affinities for their complementary RNA targets compared with the corresponding racemic oligonucleotides (data not shown).
Alternating MP/DE oligonucleotides
Optimized procedures for preparing methylphosphonate oligonucleotides have been described previously (28, 30) . We found that methylphosphonite (P-III) diester intermediates are highly sensitive to hydrolysis during automated synthesis. Because of this, a specially formulated iodine oxidizer reagent (0.25% water) was used when coupling methylphosphonamidite monomer or dimer synthons. On the other hand, β-cyanoethyl phosphite triester intermediates were not sufficiently oxidized with this reagent (data not shown). Therefore, it was necessary to use both a low-water oxidant (0.25% v/v water) for the MP coupling (29) and a high-water oxidant (2% v/v water) for the DE couplings. An auxiliary well on the DNA synthesizer was used for each oxidant and the oxidation cycles were reprogrammed as part of the respective coupling subroutines.
Isobutyryl-protected cytidine bases were used throughout this work, since benzoyl-protected cytidine is known to transaminate with the ethylenediamine deprotection reagent (28) . Most of these bases are commercially available; isobutyryl-protected 2′-O-methyl cytidine was synthesized as previously described (24) .
Chirally enhanced MP oligonucleotides
The structures of the various backbone analogs prepared with R P MP dimer synthons are shown in Figure 1 . Dimer synthons were coupled sequentially using automated solid phase chemistry (Fig. 3) . For alternating (R P MP)/(racemic MP) oligonucleotides, the synthesis cycles were as reported for racemic MPOs (28, 30) . Each coupling reaction was run for only 1 min and a low-water oxidizer reagent was used (0.25% water) to minimize hydrolysis of the P-III methylphosphonite intermediate (30) . The coupling reactions for all-2′-deoxy and all-2′-O-methyl R P MP/DE oligonucleotides were increased to 2 and 3 min respectively. Normal-water oxidizer reagent (2% water) was used for both types of R P MP/DE oligonucleotides.
In our initial experiments, extremely poor coupling efficiencies (<10%) were obtained with these dimer synthons, despite their high purity as determined by 31 P NMR and HPLC. Based on 1 H NMR experiments, we determined that water content greatly attenuates the coupling efficiencies of these dimer synthons, particularly the methylphosphonamidite derivatives. Dissolving the synthons in dry acetonitrile and drying over 3 Å molecular sieves for a minimum of 24 h typically increased coupling efficiencies to >95%.
Following coupling of the last dimer, oligonucleotides were cleaved from the support and the base protecting groups were removed using a one-pot procedure initially developed in our laboratory for use with racemic MPOs (28) .
Biophysical studies
The effects of R P versus S P dimer substitutions on all-MP backbone oligomer-RNA duplex stability are shown in Table 1 . These data show that the enhancement in binding affinity that occurs with R P chiral enrichment is almost equal in magnitude to the reduction in affinity that occurs with S P chiral enrichment. No attempt was made to correct the two-state model values for the mixture of species found in the racemic MP backbone.
The thermodynamic stability of a racemic methylphosphonate-RNA duplex can increase on replacing the racemic methylphosphonate by the R P chiral methylphosphonate, a racemic phosphorothioate or a phosphate (Table 2 ). An additional gain in stability of RNA hybrids is possible by replacing the 2′-deoxyribose by a 2′-O-methyl ribose; this modification should shift the sugar conformation to the RNA A-form.
Native gels of selected antisense oligonucleotide/RNA complexes gave binding constants within an order of magnitude of the values from melting curves for phosphodiester, alternating R P MP/DE and 2′-O-methyl alternating (fast isomer MP)/DE backbones (data not shown). No duplex was found for the racemic methylphosphonate-RNA duplex within the experimental concentration range. These gels showed no bands corresponding to triplex or higher order associations, even at extreme ratios of oligomer to RNA. 
Nuclease stability studies
Several of the analogs shown in Table 2 were tested for their ability to resist nucleolytic degradation in various biological extracts in vitro (Table 3) . Oligonucleotides were incubated in the presence of serum or cell lysates at 37_C. Aliquots were removed at specific time intervals and analyzed by reversed phase HPLC to determine the remaining full-length oligonucleotide. The 2′-deoxy alternating R P MP/DE backbone analog is 25-to 300-fold more resistant to nuclease degradation, as compared with the unmodified DE oligonucleotide. The 2′-O-methyl alternating MP/DE backbone analog is almost completely resistant to degradation in these studies.
The 2′-O-methyl alternating (fast isomer MP)/DE backbone oligonucleotide was also tested for resistance to metabolic breakdown in vivo. This oligonucleotide was labeled with tritium at one of the methylphosphonate groups (36) and injected into male Sprague-Dawley rats via a single bolus tail vein injection (average dose 2 mg/kg). Blood aliquots were removed at specified time intervals via a cannula and centrifuged to separate the plasma for HPLC analysis (see Materials and Methods). Negligible radioactivity was associated with the cell pellets, so only the plasma samples were analyzed. Urine was collected from separate animals and analyzed by HPLC in a similar manner. More than 80% of the full-length oligomer was measured in blood samples taken 45 min post-dosing (the signal-to-noise ratio was too poor at later time points to obtain a reasonable integration of the main peak). Furthermore, >80% of the radioactive sample was excreted into the urine as intact oligomer during the first 4 h.
DISCUSSION
Racemic MPOs are reported to selectively inhibit mRNA translation in cell-free and cell culture assays in the micromolar range (6) (7) (8) (9) 37) . A number of investigators have suggested the possibility of enhancing the potency of MPOs through stereoselective synthesis and/or chiral selection (12) (13) (14) (17) (18) (19) (20) (21) (22) (38) (39) (40) . According to our data, MPOs enriched in R P linkages bind stronger than MPOs enriched in S P linkages to complementary RNA. These results suggest that MPO diastereomers prepared by a conventional (racemizing) method have a broad range of binding affinities for RNA.
This study clearly demonstrates the enhanced binding of chirally pure mixed sequence MPOs to complementary RNA. Our binding studies were performed with synthetic RNA targets rather than DNA, since the intended intracellular antisense targets are mRNAs. Furthermore, we recognized that binding data obtained with DNA targets are not necessarily good predictors of binding to RNA due to the structural differences between these two targets. For example, duplexes formed with RNA targets are reported to have an A-form geometry, whereas duplexes formed with DNA can form a variety of different geometries depending on the solvent conditions and crystal packing forces (41) .
Computer modeling of the 2′-deoxy MPO/RNA heteroduplex in an A-form helix suggests that S P chiral methyl groups destabilize the duplex by pointing inward toward the major groove, causing unfavorable steric interactions with the sugar protons and bases of the MPO strand (T.A.Larsen, personal communication). Such observations are supported by molecular mechanics studies of dinucleoside methylphosphonates, wherein the S P MP linkage is found to produce a greater level of perturbation to conformations around the P-O3′ and glycosyl bonds (42) . Similarly, free energy decomposition analysis of palindromic sequences containing a single R P or S P methylphosphonate linkage predict steric effects between the C2′ and C3′ substituents on the S P diastereomer (5′-side) and C5′ substituents on the R P diastereomer (3′-side); the balance considerably favors the R P configuration (43) . A recent review describes calculated models of B-form helices (44) , which show similar trends.
The absolute configuration of the 2′-O-methyl fast isomer MP dimer is not known, but it is reasonable to suggest it is the R P isomer because of its retention on a silica gel in analogy with the 2′-deoxy series (15, 16) . On the other hand, it is possible that the 2′-O-methyl group plays a more significant role in hybridization affinity than we expect. For this reason, we cannot assume the fast isomer is R P . Dimer configuration will be determined by both X-ray crystallographic and two-dimensional NMR experiments.
While the thermodynamic effects on the R P MP and S P MP chiral centers is nearly equal and opposite, the effects of other modifications are not necessarily additive, based on our limited dataset. Converting a single R P MP linkage to diester gives an average increase of 5-fold in K a (moving the equilibrium toward the duplex) and +0.4_C in T m ; the average change in the thermodynamic cycle converting a R P center to racemic methylphosphonate and then from racemic methylphosphonate to a diester shows no change in K a and only a +0.1_C increase in T m (these differences were calculated from the average values of converting racemic MP to R P MP centers, R P MP to DE centers and racemic MP to DE centers for the oligomers presented here; data from 2′-O-methyl-modified oligomers were not included in this calculation). It is clear that describing the thermodynamic effects of R P MP and S P MP chiral centers will require a much larger data set than the few oligonucleotides of limited sequence described here. Nevertheless, these data support the relative stabilities of R P and S P methylphosphonate centers based on structural models.
These studies do not indicate why chirally pure methylphosphonate: RNA duplexes are less stable than phosphate: RNA duplexes with identical sugar chemistry. Methylphosphonate and other neutral backbones were thought to bind tighter to natural nucleic acids due to lack of charge repulsion. There are many potential reasons for the weaker interaction seen here. The methyl group of the methylphosphonate may be sterically unfavorable, even in the preferred R P configuration. The neutral backbone in the duplex may perturb the network of ordered water molecules along the major groove typically seen in A-DNA systems (45) . Finally, the free methylphosphonate strand may compress, since there is no charge-charge repulsion between phosphates; the collapsed methylphosphonate strand would require additional energy to expand the oligomer for duplex formation and so the singlestranded form would be favored over the duplex. Further study will be required to determine the reason for this difference in hybridization stability, including more in-depth thermodynamic studies, structural studies and comparisons with other uncharged backbones, such as PNAs (46) , phosphonates (47) and phosphoramidates (48) .
The alternating racemic MP/DE backbone oligonucleotide containing 2′-O-methyl sugar modifications is highly resistant to nuclease degradation. This is particularly evident from our in vivo rat data, where this analog type is found to be highly stable in the blood and excreted mostly intact into the urine.
CONCLUSION
These chirally pure, partially charged oligomers hybridize better to RNA than racemic MP oligomers, as shown by melting curves and gels. The 2′-O-methyl alternating MP/DE compounds tested here degrade more slowly than DE oligomers in vivo and in vitro. This research shows that these systems have great promise as pharmacological agents. In vitro studies will be discussed in other papers (B.D.Brown, manuscripts in preparation).
